Rating: Neutral | Target Price: HKD 8.8–11.8 (base-case fair value range) | Current Price: HKD 10.42 (closing price 2026-10-06) | Market Cap: HKD 13.26 billion (approx. RMB 11.325 billion, at 1 HKD = 0.8541 RMB) | Margin of Safety: approx. −16% (no margin of safety) | Time Horizon: 6–12 months | 52-week price range approx. HKD 7.0–13.0
China XLX is a coal-based integrated leader positioned at the far left of China's urea industry cost curve: in 2026H1, despite coal prices rising +20% YoY, urea unit cost fell another 6% to approx. RMB 1,244/ton, and volume-and-price gains drove net profit attributable to shareholders to RMB 921 million (+53.6%), at the upper end of the positive profit alert range. The volume growth thesis is highly certain — Xinxiang (approx. 1.05 million tons of urea) in 2026Q3, Zhundong in 2026Q4, and Guangxi in 2027Q3 will come onstream in sequence, lifting urea capacity from 5.05 to 8.05 million tons (+59%); normalized earnings center is expected to shift up from the FY2022-2025 adjusted average of RMB 1.09 billion to approx. RMB 1.4–1.8 billion. However, the industry is in a phase of oversupply and grinding along the cost line (2026 is a major year for new capacity, domestic surplus is in the millions of tons, inventories are elevated), and management has explicitly indicated urea prices will fall in H2, making full-year earnings front-loaded and back-loaded; highly leveraged expansion (interest-bearing debt of RMB 19.9 billion, gearing ratio 67.8%) further constrains return elasticity. At the current price of HKD 10.42, back-solving via 6–8x normalized P/E implies approx. RMB 1.4–1.9 billion of normalized earnings, with the midpoint roughly in line with the RMB 1.6 billion estimated in this report, only 1.4% below CICC's target price of HKD 10.57 — the volume growth thesis has been fully priced in by the market; the odds are roughly symmetric with a fat left tail, hence rating "Neutral" with no margin of safety; allocation value only emerges upon a pullback to HKD 8.8–10 (base-case fair value floor / near book value per share of HKD 9.82) or upon right-side signals such as a substantive relaxation of export quotas or urea prices holding steady above RMB 1,900/ton.
Notes on methodology and limitations: the company's approx. RMB 1,244 figure is a production-cost measure estimated from the interim report and is not directly comparable with industry bodies' fully-loaded cost measure; "cost approx. 10% below industry" is CICC's estimate for 2025. Moreover, 2026H1 actually saw volume and price rise in tandem (average price +2%); the real test of "volume gains offsetting price declines" comes in H2, which management has explicitly indicated will see price pullbacks — rising coal prices lift the industry's marginal cost curve and accelerate the exit of high-cost capacity, which is relatively favorable to the low-cost leader, but if capped by RMB 1,850 supply-security price limits, the company's spread will also be squeezed. Whether unit gross profit can hold near RMB 400 in 2026Q4 will be the first real test of this thesis.
This report estimates a normalized center of approx. RMB 1.6 billion (range RMB 1.4–1.8 billion). Bearish market views consider this optimistic: using the FY2024–2025 cyclical trough adjusted average of RMB 927 million as the base, proportional capacity elasticity supports only approx. RMB 1.48 billion; compound fertilizer's current annualized sales of approx. 3.07 million tons against 4.48 million tons of capacity implies utilization of only approx. 69%, with the bottleneck in channels rather than capacity; depreciation during the ramp-up at new bases (2026H1 depreciation RMB 1.059 billion, +20%) and interest expense (finance costs RMB 280 million, +22%) also erode earnings; H1 chemicals gross profit includes a geopolitical-conflict-driven temporary premium (melamine priced RMB 1,500/ton higher in the EU, methanol +31% QoQ in Q2). These constraints are reflected in the lower end of the range — a center near RMB 1.48 billion would mark the pessimistic boundary of this thesis. Management's commissioning commitments have been fulfilled for three consecutive periods (Jiujiang Phase II, POM + Guangxi Phase I, Xinxiang synthetic ammonia), indicating low execution risk.
Methodology note: there is an institutional divergence of approx. 10% in year-end total industry capacity (futures institutions' Q4 report: 77.8 million tons vs industry media: 86 million tons; net new capacity 3.5–6.0 million tons); this report presents both figures without taking a single pessimistic value. Enterprise inventories of approx. 1.4757 million tons at end-September 2026 are elevated, and industry theoretical profits turned broadly negative in September — the rebalancing path of "losses → production cuts → price floor" is starting, but downside price pressure before 2026Q4 winter storage has not eased. The net impact of rising coal prices on the company depends on pass-through to urea prices — 2026H1 already demonstrated the hedging ability of "coal up 20% while unit cost down 6%"; the truly adverse combination is "continued coal price rises + RMB 1,850 price cap" squeezing both ways. If Q4 spot breaks below RMB 1,650/ton, FY2026 attributable profit carries downside revision risk below RMB 1.4 billion.
Net debt of approx. RMB 17.1 billion is approx. 1.6x attributable equity; FCF has been negative for two consecutive years (FY2024 −RMB 1.25 billion, FY2025 −RMB 2.44 billion), with dividends + buybacks (approx. RMB 550 million/year) currently funded by debt expansion. Stress test: at a urea trough of RMB 1,600/ton, attributable profit would be RMB 850–950 million and net debt/EBITDA would rise to approx. 4.2–4.3x, putting dividend/buyback pressure on compression (this is an inference — the company's historical behavior has actually been to increase payouts at the bottom, with FY2025 dividends +23% and continuous buybacks); however, borrowings due within one year account for only 19.6%, 92% of short-term working loans are replaceable, project loan rates are as low as 2.85%, and RMB 18.5 billion of unused credit covers debt due within one year approx. 4x — the trough is survivable. One caveat: credit lines are not unconditionally accessible, and bank covenant terms could tighten if gearing continues to rise.
The market's published target range is HKD 10.57–14.57, with the current price near the lower end — even the most pessimistic named sell-side firm does not consider the current price overvalued, while the bull side (aggregate basis) sees approx. 37% upside. This report's three scenarios (bear HKD 3.5–4.8 / base HKD 8.8–11.8 / bull HKD 14.7–19.0, probabilities 20%/55%/25%) yield a probability-weighted fair value of approx. HKD 10.7, about +3% vs current price: upside to the base-case upper bound +13%, to the bull-case upper bound +82%; downside to the bear-case upper bound −54%, lower bound −66% — odds broadly symmetric with fat tails. The neutral conclusion is first-order sensitive to multiple assumptions: if the market normally assigns 9–10x (A-share peer range), implied normalized earnings are only RMB 1.1–1.25 billion, flipping the conclusion to "the market is still pricing a cyclical trough, an undervaluation exists"; conversely, if HK small-cap liquidity discount deepens to 5–6x, the conclusion turns to overvaluation. This is why this thesis's confidence is only 0.60.
| Metric | FY2023 | FY2024 | FY2025 | 2026H1 (latest period) |
|---|---|---|---|---|
| Revenue (RMB 100m) | 234.8 | 231.3 | 253.5 | 157.4 |
| YoY | +1.7% | −1.5% | +9.6% | +24.3% |
| Net profit attributable (RMB 100m) | 11.87 | 14.59 | 9.32 | 9.21 |
| YoY | −10.5% | +23.0% | −36.1% | +53.6% |
| Adjusted attributable net profit (RMB 100m) | 11.87 (est.) | 9.21 | 9.32 | 9.40 (est.) |
| Gross margin | 17.8% | 17.0% | 15.0% | 19.3% |
| Attributable net margin | 5.1% | 6.3% | 3.7% | 5.8% |
| Operating cash flow (RMB 100m) | 54.56 | 33.50 | 33.77 | — |
| Free cash flow (RMB 100m) | +21.0 | −12.5 | −24.4 | — |
| Cash and equivalents (RMB 100m, period end) | — | 8.87 | 11.99 | 27.90 (plus pledged time deposits of 2.13 not counted) |
| Interest-bearing debt (RMB 100m, period end) | 116.33 | 128.55 | 163.97 | 198.99 |
| Gearing ratio | 63.9% | 61.5% | 66.0% | 67.8% |
| Net debt/EBITDA (x) | — | — | approx. 3.7 | approx. 2.9 (annualized) |
| Urea unit gross profit (RMB/ton) | 674 | 482 | 366 | 460 |
| Full-year DPS (RMB) | 0.24 | 0.26 | 0.32 | No interim dividend (practice) |
Note: Adjusted basis — FY2023 had no material one-off gains/losses (est. ≈ attributable); FY2024 attributable profit included an investment gain of RMB 740 million from the disposal of Tianxin Coal Mine equity (RMB 673 million after tax), with the company disclosing adjusted profit of RMB 921 million; FY2025 adjusted = attributable (company disclosure); 2026H1 is this report's estimate (adding back disposal loss of RMB 21 million and excluding derivative and equity fair value gains of RMB 4 million; not adopting the add-back of share-based compensation expense the company used in 2025H1). Free cash flow = operating cash flow − cash paid for plant and equipment (FY2023/24/25: RMB 3.353/4.598/5.816 billion).
Reasons for metric changes (items with YoY ≥±20%): ① FY2024 attributable +23.0% and FY2025 attributable −36.1% both stem from one-off gain bases — FY2024 included a RMB 740 million investment gain from disposing of Tianxin Coal Mine; on an adjusted basis FY2025 was only +1.2%, and the company stated that "excluding the investment gain from the disposal of Tianxin Coal Mine equity... profit for the year declined slightly by approx. 3% YoY"; ② 2026H1 attributable +53.6% — the profit alert attributed this to "full release of economies of scale + product mix optimization, with volume and price of main products rising in tandem", plus geopolitical conflict lifting methanol/melamine prices; ③ interest-bearing debt FY2025 +27.5%, 2026H1 a further +21.4% — "all are medium-to-long-term loans, with 5–10 year ultra-long-term loans accounting for 26%", matching the three-year expansion cycle; ④ FY2025 government subsidies +45.9% to RMB 224 million (24.1% of attributable profit); ⑤ 2026H1 trade receivables +54.7% from period start — the company explained this as "reflecting the fertilizer industry's collection cycle characteristics and export logistics cycles, a normal industry operating feature", with receivables aged mainly under 3 months; ⑥ 2026H1 liquid ammonia revenue +197.3% — the Xinxiang synthetic ammonia plant commissioned in March 2026, with all new self-produced ammonia sold externally and exports achieved for the first time (Australia/South Korea, price spread approx. RMB 600/ton).
2026H1 revenue RMB 15.740 billion (+24.3%), gross profit RMB 3.033 billion (+48.7%), gross margin 19.3% (+3.2pct), attributable net profit RMB 921 million (+53.6%), at the upper end of the 31 July profit alert range (RMB 850–920 million). Driver breakdown: Volume — urea sales 2.336 million tons (+21%, Jiujiang Phase II ramp-up + Xinxiang synthetic ammonia commissioning), compound fertilizer 1.537 million tons (+12%); Price — urea average price RMB 1,704/ton (+2%), compound fertilizer RMB 2,670/ton (+3%), high-efficiency fertilizer share +4pct, black urea premium RMB 700/ton (sales +29%); Cost — urea unit cost RMB 1,244 (−6%), "economies of scale diluting unit production costs" + power consumption −19 kWh/ton; Elasticity — chemicals lifted by geopolitical conflict, melamine gross margin 38% (+7pct), liquid ammonia export spread approx. RMB 600/ton. Expenses: selling expenses +28.1% (early staffing of sales teams at new bases approx. RMB 60 million + export service fees RMB 41 million), administrative expenses +29.0% (acquisition of design institute/central research institute, compensation +RMB 110 million), finance costs +21.9% (total loans +RMB 4.367 billion YoY). Vs sell-side expectations: only CICC has verified named coverage (2026E attributable RMB 1.603 billion), with H1 achieving 57% of its full-year forecast; no broad consensus database exists, and whether the market has priced this in is anchored to CICC's target price of HKD 10.57 (current price 1.4% away) — the stock rose over 6–7% on the first day after results, indicating the market has digested the volume-price structure and cost curve evidence in the interim results.
Business model in brief: an asset-heavy coal-chemical "one-head, multiple-tails" flexible co-production platform—after coal gasification into synthetic ammonia, output can be flexibly switched among urea/compound fertilizer/liquid ammonia/methanol/melamine/DMF/polyoxymethylene. Revenue is entirely cyclical commodity spot sales (2026H1: fertilizers 53.6%, chemicals 40.3%, others 6.1%), with no subscription or recurring revenue; the company has no independent pricing power over downstream buyers (fragmented farmers + price-capped supply guarantees). Profitability stems from cost leadership rather than pricing power. Differentiated premiums exist but are limited in magnitude (black urea +700 RMB/ton, melamine EU +1,500 RMB/ton, high-efficiency fertilizer +400 RMB/ton).
Cash content of earnings: OCF/net profit (including minorities) FY2023–2025 was 3.33 / 1.66 / 2.59—consistently above 1.6, indicating high cash conversion of book profit (fertilizer advance-payment model + dealer cash settlement); profit is not inflated by receivables. FCF/net profit was 1.28 / −0.62 / −1.87—from FY2024 onward CapEx exceeded OCF, with the gap reaching RMB 2.44 billion in FY2025, financed by long-term project loans. Dual check on recurring earnings: of FY2024 net profit attributable of RMB 1.459 billion, RMB 538 million came from a one-off gain on disposal of the Tianxin coal mine (non-recurring-adjusted: RMB 921 million); in FY2025, government subsidies of RMB 224 million were booked as recurring revenue, representing 24.1% of attributable net profit—excluding these, core operating profit was about RMB 710 million. Reported attributable profit relies on subsidies and one-off items and requires dual-track verification. Reverse check on the company's own definition: the 2025 interim report once added back share-based incentive expenses (RMB 35 million) as a non-recurring item—a loose definition (adjusted profit RMB 627 million > attributable RMB 599 million); the 2026 interim report stopped this practice—the tightening is a positive change.
Return on capital: ROIC fell from ~7.9% (FY2024) to 4.4% (FY2025), below the blended cost of capital—mainly because large construction-in-progress not yet capitalized dilutes the denominator; the true test of returns comes after the capex peak in 2027. Mid-cycle ROE of 15–16% (CICC 2026/27E basis) exceeds the cost of equity, so assets hold potential for excess returns after capitalization, but the company is currently in a "distorted-return investment phase."
Maintenance capex interrogation: CapEx/depreciation FY2023–2025 was 2.18 / 2.75 / 3.05—far above the 1.5 warning line, a typical capital-intensive expansion profile (FY2025 depreciation RMB 1.905 billion, capex RMB 6.02 billion). The key distinction: the current high CapEx is primarily expansionary spending on four new bases—Jiujiang/Xinxiang/Zhundong/Guangxi (contracted but not yet provided for: RMB 5.12 billion), not outlays needed to sustain existing capacity. Whether FCF turns positive after the 2027 capex peak is the critical test of "expansion, not a black hole"—until then, cash actually returned to shareholders (dividends RMB 409 million + buybacks of ~HK$100 million) is far below book profit.
Moat and red flags: moat = slurry entrained-flow gasification process + lowest-left position on the cost curve from Xinjiang's low-cost coal base (~10% below industry average) + scale as China's No.1 single-site urea capacity + high-efficiency fertilizer brand and channel (42.2% of sales and rising). Red flags: net debt of RMB 17.1 billion (1.6× attributable equity) with dividends/buybacks debt-funded; minorities' share of profit at 25–28% (new bases with minority shareholders would further dilute attributable profit); government subsidies at 24.1% of attributable profit and rising yearly; customer/supplier concentration not separately disclosed (fragmented dealer system).
Track record: pragmatic. Three "promise vs. delivery" pairs: ① The 2025 interim report committed to Jiujiang Phase II in Q3'25, Xinxiang chemical new materials in 2026Q1, and on-schedule progress at Zhundong/Guangxi—Jiujiang Phase II was confirmed operational and directly drove 2026H1 urea sales volume +21%; Xinxiang synthetic ammonia started production in March 2026 (delivered); ② The FY2024 annual report set a 2025–2027 dividend policy of "payout ratio no less than 25% and DPS no less than RMB 0.24"—FY2025 actual DPS was RMB 0.32, payout ratio 43.9% (over-delivered); ③ The FY2023 annual report committed to 60,000-ton polyoxymethylene and Guangxi compound fertilizer Phase I startup in 2024Q4—FY2024 announcements confirmed "both operational by year-end." Multiple consecutive delivery of capacity timelines implies high guidance credibility.
Shareholder-friendliness: friendly (discounted during expansion). Payout ratio rose four years running: 23.2% → 24.6% → 26.0% → 43.9%; four consecutive years of buybacks (FY2023 HK$39.15 million cancelled → 2026H1 HK$42.53 million at HK$8.81–10.28; a further 2.134 million shares / HK$21.44 million on September 24–25), with remaining buyback mandate up to 9.77% of issued shares; no new-share issuance dilution since FY2024 (one issuance of mandatory convertible instruments in 2022). Reservation: the buyback price level has risen to ~HK$10 (vs. HK$3.4–4.5 in 2023–2024), marginally reducing capital-allocation value; during expansion, shareholder returns run parallel to CapEx and are entirely debt-financed.
Risk signals: related-party transactions minimal (related receivables RMB 0.3 million / payables RMB 28.7 million); no signs of major-shareholder share pledges, concentrated insider selling, or change of control (controlling shareholder Liu Xingxu indirectly holds ~34.8% via Pioneer Top Holdings, and added at HK$3.50 in March 2024); in July 2026 one independent non-executive director was re-designated as non-executive director (minor governance adjustment, not anomalous); the company is acquiring minority stakes in subsidiaries at a premium (RMB 136 million paid in 2026H1, raising the parent's stake to 82.77%)—friendly to minority shareholders, slightly negative for the attributable P&L (eliminates future minority dilution).
2026H1 segment performance (97.9% of revenue; remainder due to rounding):
| Segment | Revenue share | Gross margin | Revenue YoY | One-line business logic |
|---|---|---|---|---|
| Urea | 25.3% | 27% (+6pct) | +23.4% | Lowest-cost coal-based integrated tier; new capacity ramping; primary profit driver |
| Compound fertilizer | 26.1% | 16% | +15.1% | Dense distribution + high-efficiency fertilizer premium; gross profit RMB 638 million, second-largest profit source |
| Methanol | 12.3% | 7% (−1pct) | +17.6% | Trading at 60% of volume dilutes margins; self-produced portion feeds downstream |
| Liquid ammonia | 10.1% | 16% (+3pct) | +197.3% | Xinxiang ammonia startup + export growth; biggest elasticity |
| Other chemicals (incl. trading) | 9.0% | 20% | — | Humic acid / vehicle urea, etc. |
| DMF | 4.2% | 27% (+9pct) | +12.6% | Rising pharma-grade share + coal-to-methanol integrated cost advantage |
| Others (gases/equipment/pharma intermediates) | 6.1% | 18% | −8.3% | Specialty gases extending toward semiconductor grade; small base |
| Melamine | 2.9% | 38% (+7pct) | +20.3% | ~80% exported, EU premium of RMB 1,500/ton; best-quality earner |
| Polyoxymethylene | 1.9% | 20% (+8pct) | +26.6% | Anti-dumping tailwind + import substitution; new growth driver ramping |
Profit drivers: estimated by "revenue share × gross margin," urea contributed gross profit of RMB 1.069 billion, 35.2% of group gross profit (No.1), and compound fertilizer RMB 638 million, 21.0%—urea delivers over a third of gross profit on a quarter of revenue, the profit bedrock; liquid ammonia/melamine/DMF and other chemicals together provide an elasticity layer of ~RMB 1.56 billion in revenue. The gross-margin spread across segments reaches 31pct (melamine 38% vs. methanol 7%): the former is a scarce-capacity premium under export pricing + EU anti-dumping protection; the latter is bulk flow-through with 60% trading mix—reflecting pricing-power differences between "export-premium vs. domestic bulk" products on the same coal gasification platform; the value of flexible co-production lies precisely in switching toward high-margin products (demonstrated during the 2026H1 geopolitical conflict window). Fertilizers (urea + compound) together contribute ~56% of gross profit—the ballast through cycles; chemicals provide elasticity and geopolitical optionality.
Accounting red flags: ① Loose non-GAAP definition (medium)—the 2025 interim report once listed RMB 35 million of share incentive expenses as a non-recurring add-back, resulting in "adjusted profit RMB 792 million > attributable RMB 599 million," treating annually recurring expenses as one-offs; no longer presented in the 2026 interim report—remediated; ② Rising dependence on government subsidies (medium)—FY2023/24/25 of RMB 143/154/224 million respectively, or 24.1% of FY2025 attributable profit, booked as recurring revenue with doubtful sustainability (the 15% preferential high-tech tax rate also faces review); ③ Receivables +54.7% in half a year (low)—growth ~2.2× revenue growth; management provided an explanation (industry payment cycles + export logistics) and aging is mostly under 3 months; flagged for observation.
Cross-period consistency: ① Blended gross margin 18.8% (FY2022) → 17.8% → 17.0% → 15.0% (FY2025), falling four years straight before rebounding to 19.3% in 2026H1—consistent with management's explanations (urea price declines exceeding cost declines) and with urea ASP of 2,323 → 1,928 → 1,745 RMB/ton; ② Interest-bearing debt 116 → 129 → 164 → 199 billion RMB, gearing rising from 63.9% → 67.8%—consistent with management's explanation (concentrated base-construction phase; new borrowings all medium/long-term loans); ③ Operating cash flow stabilized after −38.6% in 2024 (3.350 → 3.377 billion RMB), with OCF/net profit always >1.6 and no sign of profit inflation, but management gave no specific explanation for the sharp 2024 OCF decline (results announcements lack a cash flow statement, visible only in annual reports)—a minor disclosure flaw.
Current market data: price HK$10.42 (2026-10-06 close), market cap HK$13.26 billion (RMB 11.325 billion), free float 1.2725 billion shares. PE(TTM) ~9.0–9.2× (82nd percentile over 5 years, but TTM includes 2026H1 geopolitical premium and cost-push price hikes, so earnings are unrepresentative—percentile for reference only); static PE (FY2025) 12.85× (mechanically high due to cyclical-trough profit; same caveat); PB 1.08× (75th percentile over 5 years); PS 0.40×; dividend yield 3.6%. Forward: on CICC's 2026E/2027E EPS, 7.1× / 6.3×; PEG (2025–27E CAGR 39%) ~0.16—the denominator is apparent growth from capacity ramping + low base, biasing PEG understated; no final judgment drawn.
Peer comparison (2026-10-06 multiples):
| Company | PE(TTM) | PB | 2025 attributable profit growth | ROE | Key difference |
|---|---|---|---|---|---|
| China XLX Fertiliser (01866.HK) | 9.0x | 1.08x | −36.1% (adjusted +1.2%) | ~9% (FY2025) / mid-cycle 15–16% | Coal-based urea + compound fertilizer dual core; lowest-left cost curve |
| Hualu Hengsheng (600426.SH) | 13.0x | 1.53x | −15.0% | ~11.7% | Fertilizer + diversified chemical platform; A-share liquidity premium |
| Yunnan Yuntianhua (600096.SH) | 9.5x | 2.0x | −3.4% | ~21% | Phosphate rock integration; cost driver is phosphate rock |
| Hubei Yihua (000422.SZ) | 17.2x | 2.04x | −24.3% | ~11.9% | Earnings trough inflates PE; PB more comparable |
| CNOOC Chemical (03983.HK) | 8.8x | 0.39x | −9.0% | ~4.4% | HK-listed gas-based urea; deeply discounted PB but low ROE too |
What expectations are already priced in: market cap RMB 11.325 billion ÷ 6–8× normalized PE = implied normalized attributable profit of RMB 1.42–1.89 billion (midpoint ~RMB 1.6 billion)—i.e., the market has already priced in "8.05 million tons of capacity delivered + mid-cycle urea at RMB 1,600–1,700/ton," but prices the incremental options from capacity ramping and export liberalization at close to zero (current price implies only 6.3× CICC 2027E). In one line: the current price demands the company deliver "capacity doubling, normalized profit ~RMB 1.6 billion, yet permanently worth only a 6–8× HK cyclical multiple"—broadly offset by the reality (H1 annualized RMB 1.84 billion including one-off boom conditions, capacity on schedule, left side of the cost curve); neither overextended nor obviously discounted.
Three-layer value (EPV): ① Asset value (floor) = book net assets per share HK$9.82 (attributable equity RMB 10.665 billion; PP&E at book of RMB 31.5 billion includes substantial construction-in-progress; replacement cost ≥ book)—current price is 6% above the asset floor; ② EPV at zero growth (capacity basis): normalized attributable profit RMB 1.6 billion + add-back of after-tax interest RMB 0.5 billion = unlevered earnings RMB 2.1 billion; WACC 6.5% (CoE 10.5% blended with after-tax Kd 2.5% at actual capital structure, marked up for cyclical and execution risk); after deducting net debt of −HK$15.73/share, EPV ≈ HK$14.0/share (range HK$8.4–19.4 at WACC 8%–5.5%)—on this report's unified methodology, the current price stands at a ~26% discount, i.e., the market is currently pricing a negative-growth option relative to "zero-growth value after new capacity delivery"; ③ The gap between definitions is itself the option: using full-cycle adjusted profit average of RMB 1.09 billion (old capacity structure), EPV would be only ~HK$6.8—current price ~53% above it. The huge spread between the two definitions (HK$6.8 vs 14.0) is precisely the market's pricing of the multi-year verification question "can the 8.05 million tons of new capacity earn mid-cycle profits"; this report does not treat it as support for margin of safety.
Three scenarios and odds (price HK$10.42, 2026-10-06 close):
| Scenario | Probability | Fair range (HK$) | vs. current | Key swing factors |
|---|---|---|---|---|
| Bear | 20% | 3.5–4.8 | −66% to −54% | Urea breaking below RMB 1,500/ton with sustained washout + HK small-cap liquidity contraction; trough attributable profit RMB 0.8–0.9 billion (EPS HK$0.74–0.83) × 4.5–5.5× trough multiple; cross-checked against historical PB trough of 0.36× (≈HK$3.5) and the actual 2023–2024 trading range of HK$3.4–4.5 |
| Base | 55% | 8.8–11.8 | −15% to +13% | Xinxiang/Zhundong/Guangxi on schedule; mid-cycle urea RMB 1,600–1,700/ton; normalized attributable profit RMB 1.6 billion (1.4–1.8) × 6–8× |
| Bull | 25% | 14.7–19.0 | +41% to +82% | Substantive export quota loosening + coal price decline + cycle reversal: attributable profit RMB 2.0–2.3 billion (EPS HK$1.84–2.12) × 8–9×; lower bound links to the most optimistic published street price (aggregate TP 14.57) |
Multiple anchoring rationale (independent of the company's current price): the 6× floor ≈ CNOOC Chemical's 5-year median HK peer PE of 6.3× (also a HK fertilizer name with liquidity discount); the 8× cap ≈ CICC comparable companies' 2026E average of 10.2× less HK liquidity discount to 7.3×, then marked up—near the lower end of A-share peers; A-share comparables at 9.5–17× cannot be directly transposed given market and liquidity differences. The base case's 6–8× covers this range and is not self-justified by the current multiple. Sensitivity of ±5× on normalized PE: 1–13× maps to HK$1.5–19.2—the conclusion is highly sensitive to multiple assumptions, which is the core reason for a "neutral" rather than "under/overvalued" call.
Own forecasts vs. management guidance vs. sell-side:
| Source | FY2026 revenue / attributable profit | FY2027 revenue / attributable profit | Notes |
|---|---|---|---|
| This report | RMB 30.0 billion / 1.50 billion (1.45–1.65) | RMB 34.5 billion / 1.70 billion (1.55–1.95) | H2 attributable profit RMB 530–730 million, QoQ −43% to −21% |
| Management guidance (qualitative) | — ("H2 urea prices lower than H1; chemicals returning to reasonable ranges") | — ("gearing to improve markedly and earnings to rise steadily after full ramp-up") | No quantified guidance |
| CICC (2026-07-15) | 30.47 / 1.603 billion | 35.47 / 1.810 billion | TP HK$10.57 |
Conclusion: fairly priced (fair), no margin of safety. Target price range HK$8.8–11.8 (= base-case fair value); probability-weighted fair value ~HK$10.7 (~+3% vs. current price); margin of safety (base-case fair lower bound vs. current price) about −16%. Assessing quality and price separately: quality is above average (left side of the cost curve, mid-cycle ROE 15–16%, credible management execution, rising payout ratio), while price is fair but not cheap—"capacity +59%" is already priced at a 6–8× cyclical multiple. Liquidity note: average daily turnover ~HK$20–30 million (~0.15–0.25% of market cap), low but below warning threshold; large entries/exits need to be staged.
Industry Size: Urea is China's largest fertilizer product by output. In 2025, national production was 72.013 million tonnes (+7.1%), apparent consumption 67.12 million tonnes (+0.4%), and exports 4.89 million tonnes (6.8% of output) (per China Nitrogen Fertilizer Industry Association flash estimates); at an average 2025 price of about RMB 1,694/tonne, the urea market size is roughly RMB 122 billion per year. Synthetic ammonia output was 77.687 million tonnes (+6.1%). For compound fertilizer, 2024 capacity was 184 million tonnes, output 52.66 million tonnes, demand 49.05 million tonnes (Zhuochuang, cited by CITIC Securities), with output stable at 53–57 million tonnes over the past five years. Volume growth has peaked: urea output rose from 53.70 million tonnes in 2021 to 72.01 million tonnes in 2025 (+32% over four years), but apparent consumption has been nearly flat (+0.4% in 2025), with growth absorbed by exports and inventory; the association forecasts 2026 output of 76.50 million tonnes (+6.2%), with roughly 22 million tonnes of new capacity planned for 2026–2028, about 10 million tonnes of obsolete fixed-bed capacity due for elimination over the same period, and net new capacity of about 10 million tonnes. Compound fertilizer demand fell −2.5% in 2024 — also zero growth. There is no structural demand inflection in the industry — vehicle urea (for China VI diesel vehicles) is one of the few structural growth pockets but too small to change the overall supply-demand balance; China XLX's share logic is supply-side elimination and replacement (capturing share vacated by the industry via low-cost capacity), not demand repricing.
Value Chain and Value Distribution: Coal (60–70% of urea cost) → synthetic ammonia → urea → direct agricultural application (about 70%, via county/township distributors to farmers) / secondary processing into compound fertilizer / vehicle urea and industrial uses (panels, desulfurization). Three process types: entrained-flow coal-water slurry/pulverized coal (using fine coal/lignite, lowest cost, 59% of capacity, mainstream) > fixed-bed (anthracite lump coal, highest cost, share down to 17%) > gas-based (natural gas, subject to winter gas rationing). The largest value retention accrues to coal–ammonia–urea integrated players (self-supplied ammonia + low-cost coal); standalone plants buying liquid ammonia have the thinnest margins. Toward upstream coal, integrated players have strong bargaining power via self-owned gasification + self-supplied Xinjiang coal; toward downstream farmers and distributors, the industry has weak bargaining power (fragmentation + supply-stabilizing price caps) — profits are essentially determined by the coal-to-urea price spread and export policy. China XLX sits in the core midstream of full-chain integration, with gross margin mainly retained at its urea stage (fertilizer business contributed about 71% of gross margin, per CITIC Securities 2023; urea + compound fertilizer together about 56% in 2026H1). Since November 2025, the coal price rebound (Qinhuangdao 5,500 kcal at RMB 984/tonne as of September 2026) has kept raising the industry's cost center — a squeeze-out pressure for capacity on the right side of the cost curve and a relative positive for left-side leaders.
Supply-Demand and Competitive Structure: Demand side — agricultural fertilization fluctuates slowly with grain prices/planted area; 2025 apparent consumption of +0.4% is essentially zero growth, so price elasticity can only come from export windows. Supply side — end-2025 capacity is about 79.80 million tonnes with utilization above 90% (Mysteel/association data); about 5.94 million tonnes were added in 2025, and 2026 is a "big commissioning year" (507–6,000 thousand tonnes pending, nominal growth 6.4–7.5%, by different estimates; futures desks' Q4 reports put year-end capacity at 77.80 million tonnes with net additions of about 3.5 million tonnes — a total-capacity discrepancy of about 10%; this report presents both). Supply has clearly outstripped demand: 2025 output of 72.01 million tonnes > apparent consumption of 67.12 million tonnes, with the 4.89 million tonne gap absorbed by exports; under the association's 2026 output forecast of 76.50 million tonnes plus an export quota of 3.3 million tonnes, the domestic surplus widens to the multi-million-tonne level (350–600 万 tonnes across estimates); end-September 2026 enterprise inventory was 1.4757 million tonnes, with all-in inventory above 4 million tonnes at historic highs. Concentration is low: urea capacity CR10 is about 37.4% (2023, Zhuochuang) and compound fertilizer CR10 about 27–30%, both far below the chemical industry average; entry barriers lie in coal resources and energy-consumption quotas (strict controls on new capacity and like-for-like replacement since the 14th Five-Year Plan), capex in the billions of RMB, and process learning curves. Competitive intensity is rising: the 2025 average price of RMB 1,694/tonne has fallen below most producers' cost lines (fixed-bed cash cost about RMB 1,439/tonne, entrained-flow about RMB 1,333/tonne, Zijin Tianfeng 2025.11; as of September 2026, Longzhong puts fixed-bed full cost at RMB 1,796/tonne with a national theoretical average profit of only RMB 24/tonne), pushing the whole industry into cost-line competition, with export quotas (3.3 million tonnes in 2026, −28% YoY) becoming a scarce profit channel. Substitution threat is weak: urea has no low-cost substitute as a nitrogen source; marginal substitution comes from fertilizer-reduction/efficiency policies and new-type fertilizers (a structural positive for China XLX's high-efficiency fertilizer positioning).
Cycles and Regulation: Urea is in the cost-line bottoming stage of the latter part of this downcycle (see Section XI, "Cycle Positioning and Through-Cycle Earnings"). Five regulatory levers: ① supply security and price stabilization — for March–June 2026, factory urea prices strictly capped at RMB 1,850/tonne, with preferential rail freight for production coal; ② export controls — October 2021 inspection requirements → 2025 quota system + guide price (4.89 million tonnes) → 2026 quota tightened to 3.3 million tonnes + dual inspection controls, though the pace is easing (export guide price removed in June 2026; the fourth quota tranche issued only two weeks after the third in late September, ahead of expectations; India's IPL tender of 1.7 million tonnes opened October 7); ③ commercial fertilizer reserves released during spring planting to smooth volatility; ④ dual energy-consumption controls / energy-efficiency benchmarks forcing fixed-bed exit (about 10 million tonnes, 12.5% of current capacity); ⑤ an import tariff-rate quota of 330,000 tonnes/year. Policy is neutral-to-negative for industry volumes (price caps + quotas compressing elasticity) but a structural positive for China XLX (efficiency benchmarks accelerating elimination + quotas tilting toward low-cost producers); the main policy risk is extended price caps and renewed quota tightening delaying the cycle reversal.
Peer Benchmarks: See Section IX, "Valuation and Odds," peer valuation table (Hualu Hengsheng / Yuntianhua / Hubei Yihua / CNOOC Chemical / Sichuan Meifeng). Scale ranking: China XLX's 2025 revenue of RMB 25.35 billion is on par with Hubei Yihua (RMB 25.65 billion), about 82% of Hualu Hengsheng (RMB 30.97 billion) and half of Yuntianhua (RMB 48.42 billion); but profitability is at the front — in 2026H1, when the industry's theoretical profit turned negative, it still delivered +53.6% net profit attributable to shareholders, whereas Sichuan Meifeng (a small gas-based plant in Southwest China) lost RMB 122 million in 2025, Hubei Yihua −24%, CNOOC Chemical −9%, and Hualu Hengsheng only rebounded +43% YoY in 2026Q2. This round of cost-line competition is concentrating share toward coal-based integrated leaders: gas-based (CNOOC Chemical anchored to natural gas prices) and fixed-bed capacity remain under pressure; in 2025, coal-based enjoyed a post-tax gross margin advantage of RMB 257/tonne over gas-based (Zhuochuang).
Company Industry Positioning: A cost-leadership leader, not a price setter. Urea capacity of 5.05 million tonnes (2025) ranks first nationally for a single entity, about 6.3% of industry capacity (CICC); urea/compound fertilizer sales account for 5.4%/5.2% of domestic output, with compound fertilizer in the industry top five; after the 2027 capacity expansion to 8.05/5.98 million tonnes comes online, share could rise to about 9%. Moat sources: coal-water-slurry entrained-flow process + low-cost Xinjiang coal (per-tonne cost of RMB 1,365 in the first three quarters of 2024, RMB 135/tonne below the industry average, per CITIC Securities; further down to about RMB 1,244 in 2026H1) + scale + high-efficiency fertilizer channel and brand (42.2% share). Share trend is rising: the company's incremental capacity represents over one-third of the industry's 2026 new capacity — a textbook path of "replacing industry-eliminated share with low-cost capacity." A note on market position definitions: the company's "No. 1 national single-entity urea capacity" is based on CICC/company disclosures; on a group consolidated capacity basis, China XLX is also in the first tier, but no unified third-party ranking exists for the exact urea capacity of diversified groups such as Hubei Yihua and Yuntianhua — both definitions coexist, with sources noted.
Historical Cycle Template (national spot mainstream prices, per Zijin Tianfeng Futures 2025.11 review): ① Nov 2009–Jun 2012 upcycle 1,600→2,400 RMB/tonne (+50%, 2.6 years; four-trillion stimulus + coal prices + export tariff cuts); ② Jun 2012–Oct 2016 downcycle 2,300→1,200 (−48%, 4.3 years; energy downcycle + overcapacity); ③ Oct 2016–Oct 2018 upcycle 1,200→2,090 (+74%, 2 years; supply-side reform); ④ Nov 2018–Jul 2020 downcycle 2,090→1,570 (−25%, 1.8 years; international gas price collapse); ⑤ Jul 2020–Jun 2022 upcycle 1,570→3,200 (+104%, 2 years; record coal prices + Russia-Ukraine war + food crisis); ⑥ Jun 2022–present downcycle 3,200→about 1,780 (−44%, ongoing for over 4 years; coal price decline + new coal gasification capacity + export controls). Pattern: upcycles about 2 years, downcycles 2–4 years, amplitude 50–100%; pricing anchor = domestic coal price + export policy.
Current Position: Spot price about RMB 1,780/tonne as of 2026-10-05 (SunSirs benchmark price; year range 1,570–1,892.5, median 1,731), at roughly the 29th percentile of the 2016 trough (1,200) to 2022 peak (3,200) range; −44% from the last peak, +48% from the last trough. The urea-coal price spread was at the 8th percentile since 2014 in June 2026 (CICC) — earnings are at a historic low zone with a clear cost-floor signal; but high supply (daily output of 200–210 kilotonnes at historic highs, operating rate 81.9%) + high inventory (enterprise inventory 1.4757 million tonnes) cap any rebound, forming a narrow bottoming range where "costs and exports hold up the floor while supply-security price caps and oversupply press down the ceiling." Nature of the current P/E: TTM of about 9x corresponds to "2025 trough + 2026H1 rebound" mid-to-low earnings — neither a peak-low P/E trap nor a trough-high P/E; it is mid-cycle; the static 12.85x is mechanically inflated by trough-level profit.
Supply Response: 2026 is a big commissioning year (net additions of 3.5–6 million tonnes across estimates, over 90% in H2), 2027 increments remain large, slowing before 2028; supply-demand inversion has already occurred (2025 output > apparent consumption); the rebalancing mechanism = about 10 million tonnes of fixed-bed capacity (12.5%) exiting below the cost line + export quota relief. Leading indicators: enterprise inventory drawing below 1 million tonnes, fixed-bed operating rates declining, daily output falling, and whether the domestic-overseas spread (FOB–Shandong at the 87th percentile since 2013 but locked by quotas) can be monetized through exports. Net supply growth is expected to decelerate after 2027, with the price center recovering from the cost line — the basis for the base-case "RMB 1,600–1,700/tonne mid-cycle" scenario.
Through-Cycle Earnings: Normalized (mid-cycle) EPS ≈ HK$1.47 (attributable profit RMB 1.6 billion / 1.2725 billion shares), implying a normalized P/E of about 7.1x at the current price — in the lower-middle of the 6–8x anchoring range; normalized P/E ±5x (1–13x) corresponds to HK$1.5–19.2. Trough EPS ≈ HK$0.74–0.83 (deep-trough attributable profit RMB 0.8–0.9 billion; actual 2025 profit of RMB 932 million at 5.05 million tonnes is an already-realized "price-trough year" sample, and the 2026H1 rebound confirms the earnings trough was in 2025); trough P/E of 4.5–5.5x corresponds to HK$3.3–4.6, consistent with the bear-case range. Asset-value floor: book net assets per share of HK$9.82 (P/B 1.0x); historical P/B floor of 0.36x ≈ HK$3.5 — the market has priced at this level in extreme cases (actual trading range of HK$3.4–4.5 in 2023–2024).
Downside Stress Test (2027 basis, coal at RMB 950–1,000/tonne, company urea sales about 5.4 million tonnes): urea back to the 2025 average of RMB 1,694/tonne — volume growth (+550,000 tonnes) largely offsets the price decline, attributable profit RMB 1.6–1.8 billion, mild impact; urea at RMB 1,600/tonne (S2) — urea gross margin −RMB 480 million plus chemical spread normalization −RMB 200–300 million, total gross margin about RMB 5.1–5.3 billion (−11% to −13%), attributable profit RMB 850–950 million (about −42% to −48%), net debt/EBITDA rising to 4.2–4.3x, interest coverage about 6x; liquidity: cash of RMB 2.79 billion + undrawn credit of RMB 18.5 billion vs. RMB 3.9–5.5 billion due within one year, coverage of about 4x, with 92% of short-term loans replaceable — it can weather this; no survival risk, but the ~RMB 550 million of discretionary spending on dividends/buybacks faces compression, and the multiple could de-rate from 7x toward the 5–6x trough. Extreme case (urea at RMB 1,400–1,450/tonne for a full year): attributable profit RMB 200–400 million, net debt/EBITDA exceeding 6x, requiring suspension of dividends/buybacks + a 40% cut to capex — probability <10% (would require breaking the 2025 spot low of RMB 1,570 by a further 15–20% and persisting for over a year).
Management's Cycle Discipline: During the 2023–2025 earnings downcycle (urea ASP RMB 2,323→1,745/tonne), management counter-cyclically ramped up expansion (capex RMB 2.49→4.87→6.02 billion), explicitly stating it would "use the industry's trough cycle… to seize market share" — building at the bottom and harvesting in recovery, correct counter-cyclical behavior (the Jujiang Phase II commissioning and immediate ramp-up in 2025 validates this); meanwhile, dividends and buybacks have been maintained for four consecutive years. A retained criticism: the commissioning window (2026Q3–2027Q3) of this round's combined RMB 17.5–18.5 billion capex across Xinxiang/Zhundong/Guangxi coincides with the industry's big commissioning year and the window of overt oversupply — worse timing than the last round — and marginal per-tonne profit on new capacity will be compressed by the industry's falling price center. The timing risk of "expanding at the high" objectively exists, and returns are highly sensitive to urea prices.
Overall Rating: Neutral, confidence 0.55, time horizon 6–12 months. China XLX is a high-quality survivor and share harvester at the bottom of the urea cycle: leftmost end of the cost curve, consistent delivery on commissioning commitments, high cash conversion, rising payout ratio — quality assessed as "above average." But the current price of HK$10.42 (close, 2026-10-06) already capitalizes normalized earnings of around RMB 1.6 billion at a 6–8x normalized multiple, just 1.4% below CICC's target price; probability-weighted fair value across three scenarios is about HK$10.7 (+3%), with a safety margin of about −16% — a good company at a fair price with no discount. Strategically: holders can continue holding (dividends + buybacks + commissioning catalysts as support); incremental capital should wait for two types of signals — a price signal (pullback to HK$8.8–10, i.e., the lower edge of base-case fair value and near book value per share) or a fundamental right-side signal (substantive export quota easing, urea spot holding above RMB 1,900/tonne, better-than-expected ramp at Xinxiang/Zhundong). Key risks and monitoring items by importance: ① urea price path — a break below RMB 1,650/tonne warrants vigilance for the S2 scenario; a break below RMB 1,500/tonne (tax-inclusive) sustained for four weeks is a deep-trough warning, while holding above RMB 1,900/tonne triggers an upward revision; ② confirmation of Xinxiang/Zhundong commissioning in 2026Q4 and the January–February 2027 profit alert window (attributable profit ≥ RMB 1.398 billion triggers mandatory disclosure); ③ India IPL tender results and fourth-quota execution, plus the 2027 quota framework (tightening below 3 million tonnes is negative; easing is a bull-case trigger); ④ financial constraints — gearing breaking 70%, undrawn credit shrinking, whether dividends/buybacks are cut; ⑤ monthly verification of buybacks and changes in Stock Connect holdings (supporting force).
Data and Definitions Note: Share price and market cap based on the 2026-10-06 close of HK$10.42, at an exchange rate of HK$1 = RMB 0.8541 (cross-checked via tools on 2026-10-07); financial data from company results announcements/annual reports (fiscal year = calendar year); industry data from the China Nitrogen Fertilizer Industry Association, Zhuochuang, Longzhong, Zijin Tianfeng Futures, Mysteel, and CICC/CITIC research (sources noted); this report's own estimates (adjusted 2026H1, normalized earnings, EPV, scenario fair values) are all labeled "this report's estimate." Sell-side coverage is sparse (only CICC by name), so consensus estimates have limited representativeness.